Literature DB >> 8665524

High expression of ganglioside alpha-2,8-sialyltransferase (GD3 synthase) gene in adult T-cell leukemia cells unrelated to the gene expression of human T-lymphotropic virus type I.

M Okada1, K Furukawa, S Yamashiro, Y Yamada, M Haraguchi, K Horibe, K Kato, Y Tsuji, K Furukawa.   

Abstract

Expression of ganglioside alpha-2,8-sialyltransferase (GD3 synthetase; EC 2.4.99.8) gene and gangliosides in human leukemia cells were analyzed. Flow cytometric analysis of various types of leukemia cells using monoclonal antibodies revealed that GD3 was expressed at a moderate level on adult T-cell leukemia (ATL) cells and weakly on T-cell acute lymphocytic leukemia cells. Accordingly, high levels of GD3 synthase mRNA in ATL and low levels in T-cell acute lymphocytic leukemia were demonstrated by semiquantitative reverse transcription-PCR analysis. High-level expression of the GD3 synthase gene in ATL cells was detected in the uncultured state, and was not changed during short-term culture in vitro. This was in contrast with the rapid up-regulation of GM2/GD2 synthase gene, which was observed within 24 h after start of culture after the emergence of human T-lymphotropic virus type I (HTLV-I) gene expression in cultured normal T lymphocytes with or without HTLV-I p40tax protein, GD3 synthase gene was almost equally expressed, whereas GM2/GD2 synthase gene was much more strongly expressed in the p40tax-positive T cells. These findings indicated that the GD3 synthase gene was highly expressed in ATL cells unrelated to HTLV-I genome expression.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8665524

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  17 in total

1.  Ganglioside GD3 promotes cell growth and invasion through p130Cas and paxillin in malignant melanoma cells.

Authors:  Kazunori Hamamura; Keiko Furukawa; Takanori Hayashi; Takeshi Hattori; Junji Nakano; Hideyuki Nakashima; Tetsuya Okuda; Hideki Mizutani; Hisashi Hattori; Minoru Ueda; Takeshi Urano; Kenneth O Lloyd; Koichi Furukawa
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-22       Impact factor: 11.205

2.  Ganglioside GD3 Enhances Invasiveness of Gliomas by Forming a Complex with Platelet-derived Growth Factor Receptor α and Yes Kinase.

Authors:  Yuki Ohkawa; Hiroyuki Momota; Akira Kato; Noboru Hashimoto; Yusuke Tsuda; Norihiro Kotani; Koichi Honke; Akio Suzumura; Keiko Furukawa; Yuhsuke Ohmi; Atsushi Natsume; Toshihiko Wakabayashi; Koichi Furukawa
Journal:  J Biol Chem       Date:  2015-05-04       Impact factor: 5.157

3.  Functional activation of Src family kinase yes protein is essential for the enhanced malignant properties of human melanoma cells expressing ganglioside GD3.

Authors:  Kazunori Hamamura; Momoko Tsuji; Hiroshi Hotta; Yuki Ohkawa; Masataka Takahashi; Hidenobu Shibuya; Hideyuki Nakashima; Yoshio Yamauchi; Noboru Hashimoto; Hisashi Hattori; Minoru Ueda; Keiko Furukawa; Koichi Furukawa
Journal:  J Biol Chem       Date:  2011-03-31       Impact factor: 5.157

4.  Identification and expression of a sialyltransferase responsible for the synthesis of disialylgalactosylgloboside in normal and malignant kidney cells: downregulation of ST6GalNAc VI in renal cancers.

Authors:  Motohiro Senda; Akihiro Ito; Akiko Tsuchida; Tomoko Hagiwara; Tsuguhiro Kaneda; Yoko Nakamura; Kenji Kasama; Makoto Kiso; Kazuhiro Yoshikawa; Yoko Katagiri; Yoshinari Ono; Manabu Ogiso; Takeshi Urano; Keiko Furukawa; Shinichi Oshima; Koichi Furukawa
Journal:  Biochem J       Date:  2007-03-15       Impact factor: 3.857

Review 5.  Signaling domains of cancer-associated glycolipids.

Authors:  Koichi Furukawa; Yuhsuke Ohmi; Kazunori Hamamura; Yuji Kondo; Yuki Ohkawa; Kei Kaneko; Noboru Hashimoto; Farhana Yesmin; Robiul H Bhuiyan; Orie Tajima; Keiko Furukawa
Journal:  Glycoconj J       Date:  2022-03-22       Impact factor: 2.916

Review 6.  Glycosylation of glycolipids in cancer: basis for development of novel therapeutic approaches.

Authors:  Jose L Daniotti; Aldo A Vilcaes; Vanina Torres Demichelis; Fernando M Ruggiero; Macarena Rodriguez-Walker
Journal:  Front Oncol       Date:  2013-12-19       Impact factor: 6.244

7.  Multiplex bead-based measurement of humoral immune responses against tumor-associated antigens in stage II melanoma patients of the EORTC18961 trial.

Authors:  Judith Michels; Natalia Becker; Stefan Suciu; Iris Kaiser; Axel Benner; Zeynep Kosaloglu-Yalcin; Sandrine Agoussi; Niels Halama; Michael Pawlita; Tim Waterboer; Stefan B Eichmüller; Dirk Jäger; Alexander M M Eggermont; Inka Zörnig
Journal:  Oncoimmunology       Date:  2018-02-12       Impact factor: 8.110

8.  Differential roles of gangliosides in malignant properties of melanomas.

Authors:  Yuhsuke Ohmi; Mariko Kambe; Yuki Ohkawa; Kazunori Hamamura; Orie Tajima; Rika Takeuchi; Koichi Furukawa; Keiko Furukawa
Journal:  PLoS One       Date:  2018-11-21       Impact factor: 3.240

Review 9.  Molecular recognition of gangliosides and their potential for cancer immunotherapies.

Authors:  Ute Krengel; Paula A Bousquet
Journal:  Front Immunol       Date:  2014-07-21       Impact factor: 7.561

10.  An anti-GD2 monoclonal antibody enhances apoptotic effects of anti-cancer drugs against small cell lung cancer cells via JNK (c-Jun terminal kinase) activation.

Authors:  Shoko Yoshida; Haruhiko Kawaguchi; Shigeki Sato; Ryuzo Ueda; Koichi Furukawa
Journal:  Jpn J Cancer Res       Date:  2002-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.